CJC-1295: The GHRH Analog You're Probably Using Incorrectly
PotentPeptide
Back to All Topics
CJC-1295: The GHRH Analog You're Probably Using Incorrectly research artwork
Research
Research Article 3 min read

CJC-1295: The GHRH Analog You're Probably Using Incorrectly

Most people researching 'CJC-1295' are actually looking for its short-acting cousin, Mod GRF 1-29. This GHRH analog is designed to create natural, pulsatile bursts of growth hormone, not the sustained 'GH bleed' caused by the original long-acting version with DAC. It's the foundation of modern GH peptide stacks, almost always paired with a GHRP like Ipamorelin for a powerful synergistic effect on recovery and body composition.

Backed by 4 references

Compare research notes with product details, vendor context, dosing ranges, and FAQ answers. View the CJC-1295 product page .

CJC-1295 is a growth hormone secretagogue that binds to GHRH receptors on the anterior pituitary gland, triggering the synthesis and release of endogenous growth hormone.

What is CJC-1295?

CJC-1295 is a growth hormone secretagogue studied under the full name Tetrasubstituted 29-amino-acid peptide with Drug Affinity Complex (DAC). Researchers usually discuss it in the context of growth hormone secretagogue, with attention to mechanism, dose range, safety signals, and product quality. This profile separates compound-specific research notes from vendor claims and personal protocol decisions. It also links the profile to product research context. The page should be read as research context, not personal medical guidance.

How does CJC-1295 work?

CJC-1295 works through the pathway described in its product research data: CJC-1295 binds to GHRH receptors on the anterior pituitary gland, triggering the synthesis and release of endogenous growth hormone. Unlike native GHRH, the attached DAC moiety allows it to bind to serum albumin, protecting it from rapid degradation. This results in a prolonged, stable increase in GH levels, leading to a consistent elevation of IGF-1, the primary mediator of GH's anabolic effects. The practical question is whether that pathway matches the claimed outcome. Mechanistic plausibility can support a hypothesis, but it does not replace controlled human evidence, safety monitoring, or legal review.

What are the benefits of CJC-1295?

The commonly discussed benefits of CJC-1295 include increases lean body mass and muscle growth, promotes significant fat loss (lipolysis), enhances sleep quality and depth, improves recovery time from training and injury, increases bone mineral density. These benefits should be interpreted through the evidence source behind each claim. A product page may summarize use cases, but a research decision should check whether the endpoint came from human data, animal data, or mechanism-based reasoning.

What are the side effects of CJC-1295?

Reported or plausible side effects for CJC-1295 include temporary flushing and head rush sensation post-injection, water retention, particularly in the first few weeks, tingling or numbness in hands/feet (mild carpal tunnel symptoms), increased fatigue or lethargy, injection site redness, soreness, or itching. Injection-site reactions, tolerance issues, glucose changes, appetite changes, sleep changes, or hormone-marker shifts can matter depending on the compound class. Stop criteria and medical review matter more when symptoms persist or worsen.

CJC-1295 may be sold by vendors for research use only, but that label does not make human use legal or medically appropriate. FDA status, prescription rules, import rules, customs rules, and WADA rules can differ. A compound can be lawful for one research or prescription context and prohibited in sport. Competitive athletes should check the current prohibited list before handling any peptide or related compound.

Dosing context

Research discussions commonly list 500-1000 mcg at 1-2x per week for 12-16 weeks. Those values are not instructions. Dose interpretation depends on route, purity, lot testing, half-life, medical history, and the endpoint being tracked. Administer via subcutaneous injection. Best taken on an empty stomach or before bed to maximize the natural GH pulse during sleep. The long half-life means daily injections are unnecessary.

Research and monitoring notes

Track objective outcomes that match the mechanism. For CJC-1295, that may include symptom logs, training load, body weight, appetite, sleep, glucose, IGF-1, inflammation markers, or injury-specific measures depending on the research question. Avoid adding multiple new compounds at once, because adverse effects and benefits become hard to attribute.

Product comparison context

The matching product page can help compare vendor-facing details, but the research profile should come first. Read the mechanism, safety notes, legal context, and references before comparing price or availability.

Stay Updated on Peptide Research

Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.

References

More in This Category

Related Topics